Claud Grigg
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 2
-
- Renal cell carcinoma treatment 3
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Naiyer A. Rizvi (5 shared papers)Diego Chowell (1 shared paper)Timothy A. Chan (1 shared paper)Michael F. Berger (1 shared paper)Jeffrey K. Weber (1 shared paper)David Requena (1 shared paper)James M. Carroll (1 shared paper)Sviatoslav M. Kendall (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Urologic Oncology Seminars and Original Investigations (4 papers)The Journal of Urology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Claud Grigg
19 papers receiving 1.6k citations
Claud Grigg's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 965
- Immunology 440
- Pulmonary and Respiratory Medicine 511
- Cancer Research 166
- Radiology, Nuclear Medicine and Imaging 83
Countries citing papers authored by Claud Grigg
This map shows the geographic impact of Claud Grigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claud Grigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claud Grigg more than expected).
Fields of papers citing papers by Claud Grigg
This network shows the impact of papers produced by Claud Grigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claud Grigg. The network helps show where Claud Grigg may publish in the future.
Co-authors
The 25 scholars most cited alongside Claud Grigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy Hit paper breakdown → | 2017 | 784 |
| 2 | Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2020 | 443 |
| 3 | 2016 | 164 | |
| 4 | 2016 | 53 | |
| 5 | 2017 | 32 | |
| 6 | 2018 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 11 | |
| 10 | 2019 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2022 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2020 | 0 |
About Claud Grigg
Claud Grigg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Molecular Biology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (965 citations), Immunology (440 citations), Pulmonary and Respiratory Medicine (511 citations), Cancer Research (166 citations) and Radiology, Nuclear Medicine and Imaging (83 citations). Claud Grigg has collaborated with scholars based in United States. Frequent co-authors include Naiyer A. Rizvi, Diego Chowell, Timothy A. Chan, Michael F. Berger, Jeffrey K. Weber, David Requena, James M. Carroll, Sviatoslav M. Kendall, Luc G.T. Morris and Benjamin D. Greenbaum. Their work appears in journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations, The Journal of Urology, Journal for ImmunoTherapy of Cancer and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.